日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion

Lesko, N., Naess, K., Wibom, R., Solaroli, N., Nennesmo, I., von Dobeln, U., Karlsson, A., & Larsson, N. (2010). Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion. Neuromuscul Disord, 20(3), 198-203. doi:10.1016/j.nmd.2009.11.013.

Item is

基本情報

表示: 非表示:
アイテムのパーマリンク: https://hdl.handle.net/21.11116/0000-000B-81D1-6 版のパーマリンク: https://hdl.handle.net/21.11116/0000-000B-81D2-5
資料種別: 学術論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Lesko, N., 著者
Naess, K., 著者
Wibom, R., 著者
Solaroli, N., 著者
Nennesmo, I., 著者
von Dobeln, U., 著者
Karlsson, A., 著者
Larsson, N.G.1, 著者           
所属:
1Department Larsson - Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Max Planck Society, ou_1942286              

内容説明

表示:
非表示:
キーワード: Adenosine Triphosphate/metabolism Arginine/genetics Child Child, Preschool DNA Mutational Analysis/methods DNA, Mitochondrial/*genetics Female *Genetic Predisposition to Disease Humans Infant Infant, Newborn Male Mitochondria/metabolism Mitochondria, Muscle/genetics/metabolism Mitochondrial Diseases/mortality Mitochondrial Encephalomyopathies/*genetics/pathology Muscle, Skeletal/metabolism/pathology Mutagenesis, Site-Directed/methods Mutation/*genetics Thymidine Kinase/*genetics Tryptophan/genetics
 要旨: Deficiency of thymidine kinase-2 (TK2) has been described in children with early onset fatal skeletal myopathy. TK2 is a mitochondrial deoxyribonucleoside kinase required for the phosphorylation of deoxycytidine and deoxythymidine and hence is vital for the maintenance of a balanced mitochondrial dNTP pool in post-mitotic tissues. We describe a patient with two novel TK2 mutations, which caused disease onset shortly after birth and death at the age of three months. One mutation (219insCG) generated an early stop codon, thus preventing the synthesis of a functional protein. The second mutation (R130W) resulted in an amino acid substitution, which caused a severe reduction (<3%) of TK2 enzyme activity. These two novel TK2 mutations cause an extremely severe phenotype with overwhelming central nervous system symptoms not commonly seen in patients with TK2-deficiency. We conclude that the severe clinical presentation in this patient was due to a virtual lack of mitochondrial TK2 activity.

資料詳細

表示:
非表示:
言語:
 日付: 2010-032010-01-20
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: -
 識別子(DOI, ISBNなど): その他: 20083405
DOI: 10.1016/j.nmd.2009.11.013
ISSN: 0960-8966
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: Neuromuscul Disord
  出版物の別名 : Neuromuscular disorders : NMD
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 20 (3) 通巻号: - 開始・終了ページ: 198 - 203 識別子(ISBN, ISSN, DOIなど): -